BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8322496)

  • 1. Immunogen-induced enhanced pulmonary histopathology in the RSV cotton rat model.
    Hildreth SW; Baggs RR; Brownstein DG; Castleman WL; Paradiso PR
    Vaccine; 1993; 11(6):689-90. PubMed ID: 8322496
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.
    Hildreth SW; Baggs RR; Brownstein DG; Castleman WL; Paradiso PR
    Vaccine; 1993; 11(6):615-8. PubMed ID: 8322482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.
    Connors M; Collins PL; Firestone CY; Sotnikov AV; Waitze A; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1992; 10(7):475-84. PubMed ID: 1609551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
    Murphy BR; Sotnikov AV; Lawrence LA; Banks SM; Prince GA
    Vaccine; 1990 Oct; 8(5):497-502. PubMed ID: 2251875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV.
    Murphy BR; Prince GA; Lawrence LA; Croen KD; Collins PL
    Virus Res; 1990 Jun; 16(2):153-62. PubMed ID: 2385958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.
    Kakuk TJ; Soike K; Brideau RJ; Zaya RM; Cole SL; Zhang JY; Roberts ED; Wells PA; Wathen MW
    J Infect Dis; 1993 Mar; 167(3):553-61. PubMed ID: 8440926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice.
    Vaux-Peretz F; Chapsal JM; Meignier B
    Vaccine; 1992; 10(2):113-8. PubMed ID: 1539464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).
    Murphy BR; Prince GA; Collins PL; Hildreth SW; Paradiso PR
    Vaccine; 1991 Mar; 9(3):185-9. PubMed ID: 2042390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge.
    Wathen MW; Kakuk TJ; Brideau RJ; Hausknecht EC; Cole SL; Zaya RM
    J Infect Dis; 1991 Mar; 163(3):477-82. PubMed ID: 1995720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunobiology of respiratory syncytial virus: prospects for a vaccine.
    Norrby E; Akerlind B; Mufson MA
    Adv Exp Med Biol; 1989; 257():147-53. PubMed ID: 2694814
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.
    Openshaw PJ; Clarke SL; Record FM
    Int Immunol; 1992 Apr; 4(4):493-500. PubMed ID: 1591217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia.
    Gupta R; Yewdell JW; Olmsted RA; Collins PL; Bennink JR
    Microb Pathog; 1990 Jul; 9(1):13-8. PubMed ID: 2077342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination].
    Pothier P
    Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.
    Ananaba GA; Anderson LJ
    J Virol; 1991 Sep; 65(9):5052-60. PubMed ID: 1870211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.
    Walsh EE; Hall CB; Briselli M; Brandriss MW; Schlesinger JJ
    J Infect Dis; 1987 Jun; 155(6):1198-204. PubMed ID: 3553346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.
    Wagner DK; Muelenaer P; Henderson FW; Snyder MH; Reimer CB; Walsh EE; Anderson LJ; Nelson DL; Murphy BR
    J Clin Microbiol; 1989 Mar; 27(3):589-92. PubMed ID: 2715331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
    Hsu KH; Lubeck MD; Davis AR; Bhat RA; Selling BH; Bhat BM; Mizutani S; Murphy BR; Collins PL; Chanock RM
    J Infect Dis; 1992 Oct; 166(4):769-75. PubMed ID: 1527411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.